Natural Beauty Bio-Technology Limited

As of June 30, 2026, Natural Beauty Bio-Technology Limited carries a market capitalization of 930.98M, placing it among publicly traded companies globally. Its enterprise value stands at 1.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Natural Beauty Bio-Technology Limited has 2.00B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Natural Beauty Bio-Technology Limited maintains a current ratio of 0.94, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 20, 2026, Natural Beauty Bio-Technology Limited's stock has declined approximately 14.81% over the past 52 weeks. The 50-day moving average sits at 0.46, while the 200-day moving average is 0.50.

As of June 30, 2026, Natural Beauty Bio-Technology Limited holds 116.16M in cash and equivalents against 424.66M in total debt, resulting in a net debt position of 279.93M. Total book value stands at 423.52M, with working capital of -25.12M providing operational flexibility.